close
close

Guiltandivy

Source for News

    • Clinical studies

    Further evidence suggests that semaglutide reduces the risk of Alzheimer's disease
    Update Information

    Further evidence suggests that semaglutide reduces the risk of Alzheimer's disease

    A new study provides real-world evidence supporting potential repurposing of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) used to treat type 2 diabetes and obesity to prevent Alzheimer's disease (AD ) can be used. Adults with type 2 diabetes who were…

    Posted on Kathleen William
    Rwanda to use Marburg vaccine in trial as death toll rises to 12
    Update Information

    Rwanda to use Marburg vaccine in trial as death toll rises to 12

    KIGALI, Rwanda (AP) — Rwandan health authorities will begin a vaccine trial against Marburg hemorrhagic feverofficials said Sunday as the East African country tries to stop the spread of an outbreak that has killed 12 people. Rwanda, which received 700…

    Posted on Kathleen William

    ads